Blood Glucose Test Strips Market - Growth, Trends and Forecast (2020 - 2025)

The Market is Segmented by Component (blood glucose test strips), by End-user (Hospital and Personal use test strips), by Technology (Thick-film electrode strips, Thin-film electrode strips, Optical strips, and Others) and Geography.

Market Snapshot

Study Period:

2012-2024

Base Year:

2019

Fastest Growing Market:

North America

Largest Market:

North America

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

  • As a part of diabetes treatment, constant monitoring of glucose levels is required. Blood glucose levels if not monitored regularly can lead to severe complications. Diabetes management process is an expensive service. At the large scale, patients use blood glucose test strips. The retail cost of these strips varies from 50 cents per piece to as high as USD 5 per strip. 
  • Price is often a significant concern for the purchase of blood glucose test strips. Although various countries, like the United Kingdom, provide reimbursements for prescribed test strips, the majority of the patients have to pay for them from their pockets.
  • The frequency of monitoring glucose levels depends on the type of diabetes and varies from patient to patient. 
  • Type 1 diabetic patients need to check their blood glucose levels at regular intervals to monitor their blood glucose levels and adjust the insulin dosing accordingly.
  • Therefore, if a patient performs 5-6 tests in a day, the average expenditure on test strips would be over USD 180/month. These expenses add to the already high diabetes management costs and are impeding the market growth. 

Scope of the Report

The Market is Segmented by Component (blood glucose test strips), by End-user (Hospital and Personal use test strips), by Technology (Thick-film electrode strips, Thin-film electrode strips, Optical strips, and Others) and Geography.

Device typeBy ComponentBlood Glucose Test Strips
By End UserHospital
Personal
By TechnologyThick-film electrode strips
Thin-film electrode strips
Optical strips
Others
By RegionNorth AmericaUnited States
Canada
Rest of North America
Latin AmericaBrazil
Mexico
Rest of Latin America
EuropeUnited Kingdom
Germany
France
Russia
Spain
Italy
Rest of Europe
Asia-PacificAustralia
China
India
Indonesia
Japan
Malaysia
Philippines
South Korea
Thailand
Vietnam
Rest of Asia Pacific
Middle East & AfricaSaudi Arabia
South Africa
Iran
Egypt
Oman
Rest of Middle East & Africa

 

By Component (Value and Volume, 2012-2024)
Blood Glucose Test Strips
By End User
Hospital (Value and Volume, 2012-2024)
Personal (Value and Volume, 2012-2024)
By Technology (Value, 2012-2024)
Thick-film electrode strips (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)
Thin-film electrode strips (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)
Optical strips (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)
Others (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)
Geography
North America
United States (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Canada (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Rest of North America (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Europe
France (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Germany (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Italy (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Spain (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
United Kingdom (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Russia (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Rest of Europe (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Latin America
Mexico (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Brazil (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Rest of Latin America (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Asia-Pacific
Japan (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
South Korea (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
China (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
India (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Australia (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Vietnam (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Malaysia (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Indonesia (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Philippines (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Thailand (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Rest of Asia-Pacific (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Middle East & Africa
Saudi Arabia (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Iran (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Egypt (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Oman (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
South Africa (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)
Rest of Middle & Africa (Value and Volume, 2012-2024)
By Component (Blood Glucose Test Strips)
By End User (Hospital and Home)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Increased Awareness Among Type 2 Diabetic Patients is Driving the Blood Glucose Test Strips Market

  • Due to the ease in handling glucometers, patients are now preferring to use them for their personal use (home use).
  • Measuring blood glucose levels is essential to take or alter the medication accordingly, especially insulin users. Within seconds, glucometers provide the blood glucose levels with accuracy. There is constant upgradation in glucometers for better use and more efficiency.
  • Approximately 10% of diabetic population contributes to Type 1 diabetes and 90% contributes to Type 2 diabetes.
  • About 90% of Type 1 patients are using glucometer in their daily routines, and 25% of Type 2 patients are using the glucometers. 
  • Due to the sedentary lifestyle, the blood glucose levels for Type 2 diabetes patients are not under control, and this is causing the patients to regularly monitor their blood glucose levels to avoid further complications of diabetes.  
  • Thus, the aforementioned factor has increased the demand for the blood glucose test strips market.

To understand key trends, Download Sample Report

North America to Dominate the Market

  • Globally, North America accounted for the largest share of 58.33% in 2017, owing to the availability of healthcare reimbursements and the fastest adoption rate for new medical technologies.
  • Europe is also a leading region in the global blood glucose test strips market. North America is the fastest-growing region for the market and portrays a massive potential for growth in the future, due to the increasing government initiatives to combat diabetes and corporate investments to streamline R&D in diabetes.

To understand geography trends, Download Sample Report.

Competitive Landscape

  • The global blood glucose test strips market is highly fragmented, with few major manufacturers having presence in major regions of the global market, while the remaining manufacturers confine to the other local or region-specific manufacturers. 
  • The innovations in test strips are increasing and are under development. For example, the new test strip includes features, such as underfill detection, and provides the user with the ability to reapply blood when the test strip is underfilled (“second chance” sampling).

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Component (Value and Volume, 2012-2024)

      1. 5.1.1 Blood Glucose Test Strips

    2. 5.2 By End User

      1. 5.2.1 Hospital (Value and Volume, 2012-2024)

      2. 5.2.2 Personal (Value and Volume, 2012-2024)

    3. 5.3 By Technology (Value, 2012-2024)

      1. 5.3.1 Thick-film electrode strips (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)

      2. 5.3.2 Thin-film electrode strips (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)

      3. 5.3.3 Optical strips (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)

      4. 5.3.4 Others (North America, Europe, Latin America, Asia-Pacific, Middle East & Africa)

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States (Value and Volume, 2012-2024)

          1. 5.4.1.1.1 By Component (Blood Glucose Test Strips)

          2. 5.4.1.1.2 By End User (Hospital and Home)

        2. 5.4.1.2 Canada (Value and Volume, 2012-2024)

          1. 5.4.1.2.1 By Component (Blood Glucose Test Strips)

          2. 5.4.1.2.2 By End User (Hospital and Home)

        3. 5.4.1.3 Rest of North America (Value and Volume, 2012-2024)

          1. 5.4.1.3.1 By Component (Blood Glucose Test Strips)

          2. 5.4.1.3.2 By End User (Hospital and Home)

      2. 5.4.2 Europe

        1. 5.4.2.1 France (Value and Volume, 2012-2024)

          1. 5.4.2.1.1 By Component (Blood Glucose Test Strips)

          2. 5.4.2.1.2 By End User (Hospital and Home)

        2. 5.4.2.2 Germany (Value and Volume, 2012-2024)

          1. 5.4.2.2.1 By Component (Blood Glucose Test Strips)

          2. 5.4.2.2.2 By End User (Hospital and Home)

        3. 5.4.2.3 Italy (Value and Volume, 2012-2024)

          1. 5.4.2.3.1 By Component (Blood Glucose Test Strips)

          2. 5.4.2.3.2 By End User (Hospital and Home)

        4. 5.4.2.4 Spain (Value and Volume, 2012-2024)

          1. 5.4.2.4.1 By Component (Blood Glucose Test Strips)

          2. 5.4.2.4.2 By End User (Hospital and Home)

        5. 5.4.2.5 United Kingdom (Value and Volume, 2012-2024)

          1. 5.4.2.5.1 By Component (Blood Glucose Test Strips)

          2. 5.4.2.5.2 By End User (Hospital and Home)

        6. 5.4.2.6 Russia (Value and Volume, 2012-2024)

          1. 5.4.2.6.1 By Component (Blood Glucose Test Strips)

          2. 5.4.2.6.2 By End User (Hospital and Home)

        7. 5.4.2.7 Rest of Europe (Value and Volume, 2012-2024)

          1. 5.4.2.7.1 By Component (Blood Glucose Test Strips)

          2. 5.4.2.7.2 By End User (Hospital and Home)

      3. 5.4.3 Latin America

        1. 5.4.3.1 Mexico (Value and Volume, 2012-2024)

          1. 5.4.3.1.1 By Component (Blood Glucose Test Strips)

          2. 5.4.3.1.2 By End User (Hospital and Home)

        2. 5.4.3.2 Brazil (Value and Volume, 2012-2024)

          1. 5.4.3.2.1 By Component (Blood Glucose Test Strips)

          2. 5.4.3.2.2 By End User (Hospital and Home)

        3. 5.4.3.3 Rest of Latin America (Value and Volume, 2012-2024)

          1. 5.4.3.3.1 By Component (Blood Glucose Test Strips)

          2. 5.4.3.3.2 By End User (Hospital and Home)

      4. 5.4.4 Asia-Pacific

        1. 5.4.4.1 Japan (Value and Volume, 2012-2024)

          1. 5.4.4.1.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.1.2 By End User (Hospital and Home)

        2. 5.4.4.2 South Korea (Value and Volume, 2012-2024)

          1. 5.4.4.2.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.2.2 By End User (Hospital and Home)

        3. 5.4.4.3 China (Value and Volume, 2012-2024)

          1. 5.4.4.3.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.3.2 By End User (Hospital and Home)

        4. 5.4.4.4 India (Value and Volume, 2012-2024)

          1. 5.4.4.4.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.4.2 By End User (Hospital and Home)

        5. 5.4.4.5 Australia (Value and Volume, 2012-2024)

          1. 5.4.4.5.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.5.2 By End User (Hospital and Home)

        6. 5.4.4.6 Vietnam (Value and Volume, 2012-2024)

          1. 5.4.4.6.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.6.2 By End User (Hospital and Home)

        7. 5.4.4.7 Malaysia (Value and Volume, 2012-2024)

          1. 5.4.4.7.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.7.2 By End User (Hospital and Home)

        8. 5.4.4.8 Indonesia (Value and Volume, 2012-2024)

          1. 5.4.4.8.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.8.2 By End User (Hospital and Home)

        9. 5.4.4.9 Philippines (Value and Volume, 2012-2024)

          1. 5.4.4.9.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.9.2 By End User (Hospital and Home)

        10. 5.4.4.10 Thailand (Value and Volume, 2012-2024)

          1. 5.4.4.10.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.10.2 By End User (Hospital and Home)

        11. 5.4.4.11 Rest of Asia-Pacific (Value and Volume, 2012-2024)

          1. 5.4.4.11.1 By Component (Blood Glucose Test Strips)

          2. 5.4.4.11.2 By End User (Hospital and Home)

      5. 5.4.5 Middle East & Africa

        1. 5.4.5.1 Saudi Arabia (Value and Volume, 2012-2024)

          1. 5.4.5.1.1 By Component (Blood Glucose Test Strips)

          2. 5.4.5.1.2 By End User (Hospital and Home)

        2. 5.4.5.2 Iran (Value and Volume, 2012-2024)

          1. 5.4.5.2.1 By Component (Blood Glucose Test Strips)

          2. 5.4.5.2.2 By End User (Hospital and Home)

        3. 5.4.5.3 Egypt (Value and Volume, 2012-2024)

          1. 5.4.5.3.1 By Component (Blood Glucose Test Strips)

          2. 5.4.5.3.2 By End User (Hospital and Home)

        4. 5.4.5.4 Oman (Value and Volume, 2012-2024)

          1. 5.4.5.4.1 By Component (Blood Glucose Test Strips)

          2. 5.4.5.4.2 By End User (Hospital and Home)

        5. 5.4.5.5 South Africa (Value and Volume, 2012-2024)

          1. 5.4.5.5.1 By Component (Blood Glucose Test Strips)

          2. 5.4.5.5.2 By End User (Hospital and Home)

        6. 5.4.5.6 Rest of Middle & Africa (Value and Volume, 2012-2024)

          1. 5.4.5.6.1 By Component (Blood Glucose Test Strips)

          2. 5.4.5.6.2 By End User (Hospital and Home)

  6. 6. MARKET INDICATORS

    1. 6.1 Type 1 Diabetes Population (2012-2024)

    2. 6.2 Type 2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Arkray

      5. 7.1.5 Ascensia Diabetes Care

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Trivida

      10. 7.1.10 Rossmax

    2. 7.2 Company Share Analysis

      1. 7.2.1 Roche

      2. 7.2.2 Johnson&Johnson

      3. 7.2.3 Abbott

      4. 7.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

Related Reports